Related Experiment Video

Updated: Jul 3, 2025

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
11:43

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones

Published on: November 30, 2016

12.7K

Role of Post-Translational Modifications in Colorectal Cancer Metastasis

Na Peng1, Jingwei Liu2, Shuangshuang Hai1

  • 1Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Cancers
|February 10, 2024
PubMed

Insights

Post-translational modifications (PTMs) significantly impact colorectal cancer (CRC) metastasis. Understanding PTMs offers new therapeutic targets for improving CRC treatment efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Colorectal cancer (CRC) is a prevalent digestive tract malignancy.
  • CRC metastasis is a complex process influenced by genetic and epigenetic factors.
  • Post-translational modifications (PTMs) regulate protein function and are increasingly implicated in cancer progression.

Purpose of the Study:

  • To review recent advancements in understanding the role of PTMs in colorectal cancer metastasis.
  • To elucidate the molecular mechanisms underlying PTMs in CRC metastasis.
  • To discuss novel therapeutic strategies targeting PTMs for CRC treatment.

Main Methods:

  • Literature review of recent studies on PTMs and CRC metastasis.
  • Analysis of molecular mechanisms involving PTMs in cancer progression.
  • Examination of therapeutic targets and drug development related to PTMs.

Main Results:

  • Dysregulation of PTMs like phosphorylation, ubiquitination, and glycosylation is critical in CRC metastasis.
  • PTMs influence protein stability, localization, and interactions, driving the metastatic cascade.
  • Targeting PTMs presents promising avenues for novel CRC therapies.

Conclusions:

  • PTMs play a crucial role in the multi-step process of colorectal cancer metastasis.
  • Targeting specific PTMs and their pathways offers potential for improved therapeutic efficacy in CRC.
  • Further research into PTMs can lead to the development of innovative anti-cancer drugs.
Keywords:
colorectal cancermetastasispost-translational modificationstherapy

More Related Videos

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.1K
CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

2.6K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K